Background
Medical School: University of Kentucky, Lexington
Residency: University of Kentucky
Additional Study: Fellowship in vitreo-retina, Duke University Eye Center,
Durham, North Carolina
Board Certification: Ophthalmology, 1991
Research
Clinical Interests: Clinical Interests:
- Vitreoretinal Surgery
- Fluorescein Angiography
- Macular Degeneration
- Diabetic Retinopathy
Research Interests:
- Battens Disease
- Diabetic Macular Edema
- Retinopathy
- Uveitis
- Sustained Release Drug Devices
Details:
Dr. Hainsworth, MD is involved in several research projects. The AREDS 2 trial is
an NIH sponsored clinical trial to determine whether Lutein/Zeaxanthin or Fish Oil
would further decreased the risk of choroidal neovascularization in patients with
AMD. The DCCT/EDIC is a long term NIH sponsored trial following patients with type
1 diabetes to further determine benefits of careful glucose control including examining
the development of retinopathy. The DEGAS is a Pfizer sponsored trial to determine
whether injecting a study drug (siRNA to inhibit expression of hypoxia inducible
gene) improves diabetic macular edema. Dr. Hainsworth is also exploring the use
of gold nano-particles as a platform to deliver anti-angiogenic drugs to specific
targets in th eeye as a potential treatment for ocular neovascularization.
